Deaths Highlight Serious Risks and Constipation Concerns Linked to Weight

Two deaths involving patients who used tirzepatide-based weight-loss treatment have renewed concerns about rare but potentially severe complications. The cases emphasize the importance of monitoring constipation, staying hydrated, increasing doses cautiously and seeking urgent care for severe abdominal or cardiovascular symptoms.